Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.45M Buy
21,284
+344
+2% +$97.9K 0.05% 271
2026
Q1
$3.63M Buy
20,940
+2,803
+15% +$575K 0.03% 424
2025
Q4
$4.65M Buy
18,137
+1,021
+6% +$268K 0.03% 346
2025
Q3
$4.45M Sell
17,116
-1,043
-6% -$274K 0.04% 345
2025
Q2
$4.44M Sell
18,159
-3,041
-14% -$758K 0.04% 358
2025
Q1
$5.61M Buy
21,200
+3,551
+20% +$960K 0.05% 277
2024
Q4
$4.48M Buy
17,649
+137
+0.8% +$36.7K 0.04% 338
2024
Q3
$5.55M Buy
17,512
+558
+3% +$199K 0.05% 282
2024
Q2
$6.33M Sell
16,954
-5,554
-25% -$1.88M 0.06% 240
2024
Q1
$7.8M Buy
22,508
+1,093
+5% +$414K 0.08% 201
2023
Q4
$9.8M Sell
21,415
-1,676
-7% -$826K 0.12% 148
2023
Q3
$11.2M Buy
23,091
+343
+2% +$161K 0.15% 115
2023
Q2
$10.2M Sell
22,748
-1,154
-5% -$581K 0.14% 123
2023
Q1
$11.6M Buy
23,902
+427
+2% +$211K 0.17% 112
2022
Q4
$12M Buy
23,475
+2,311
+11% +$1.21M 0.19% 103
2022
Q3
$10.3M Buy
21,164
+2,088
+11% +$1.02M 0.2% 95
2022
Q2
$8.93M Buy
19,076
+10,679
+127% +$4.75M 0.18% 106
2022
Q1
$3.65M Buy
8,397
+293
+4% +$123K 0.06% 249
2021
Q4
$3.76M Buy
8,104
+1,610
+25% +$712K 0.06% 251
2021
Q3
$2.53M Sell
6,494
-648
-9% -$275K 0.05% 305
2021
Q2
$3.16M Sell
7,142
-3,461
-33% -$1.51M 0.06% 264
2021
Q1
$4.45M Sell
10,603
-8,195
-44% -$3.27M 0.09% 185
2020
Q4
$7.71M Sell
18,798
-7
-0% -$2.91K 0.17% 107
2020
Q3
$7.78M Sell
18,805
-1,782
-9% -$717K 0.19% 102
2020
Q2
$7.98M Buy
+20,587
New +$7.7M 0.21% 102

Other funds holding HUM

Xponance's HUM Position: Q2 2026 in Review

Xponance increased its Humana (HUM) stake by 1.6% in Q2 2026, buying an estimated $97.9K and bringing the position to 21,284 shares worth $8.45M. The position accounts for 0.05% of the portfolio, ranked #271.

Xponance first reported a position in HUM in Q2 2020 and has held it in 25 quarters since. The position peaked at $12M in Q4 2022. 923 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Xponance held 21,284 shares of Humana worth $8.45M as of Q2 2026.
  • Xponance bought 344 Humana shares in Q2 2026, an estimated $97.9K.
  • Humana made up 0.05% of Xponance's portfolio in Q2 2026, its #271 holding.
  • Xponance first reported a position in Humana in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Humana position peaked at $12M in Q4 2022.
  • 923 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.